Clinical trials
Completed Phase 2 Carcinoma, Lobular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ARCAGY/ GINECO GROUP | 1 |
| Asan Medical Center | 1 |
| City of Hope Medical Center | 1 |
| Radiation Therapy Oncology Group | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| Rutgers, The State University of New Jersey | 1 |
| University of Alabama at Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Lobular | 7 |
| Breast Neoplasms | 5 |
| Carcinoma, Ductal, Breast | 5 |
| Inflammatory Breast Neoplasms | 3 |
| Breast Carcinoma In Situ | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Stomach Neoplasms | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.